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Background: Standard 3′ Affymetrix gene expression arrays have contributed a significantly higher volume of
existing gene expression data than other microarray platforms. These arrays were designed to identify differentially
expressed genes, but not their alternatively spliced transcript forms. No resource can currently identify expression
pattern of specific mRNA forms using these microarray data, even though it is possible to do this.
Results: We report a web server for expression profiling of alternatively spliced transcripts using microarray data
sets from 31 standard 3′ Affymetrix arrays for human, mouse and rat species. The tool has been experimentally
validated for mRNAs transcribed or not-detected in a human disease condition (non-obstructive azoospermia,
a male infertility condition). About 4000 gene expression datasets were downloaded from a public repository.
‘Good probes’ with complete coverage and identity to latest reference transcript sequences were first identified.
Using them, ‘Transcript specific probe-clusters’ were derived for each platform and used to identify expression status
of possible transcripts. The web server can lead the user to datasets corresponding to specific tissues, conditions
via identifiers of the microarray studies or hybridizations, keywords, official gene symbols or reference transcript
identifiers. It can identify, in the tissues and conditions of interest, about 40% of known transcripts as ‘transcribed’ ,
‘not-detected’ or ‘differentially regulated’. Corresponding additional information for probes, genes, transcripts and
proteins can be viewed too. We identified the expression of transcripts in a specific clinical condition and validated
a few of these transcripts by experiments (using reverse transcription followed by polymerase chain reaction). The
experimental observations indicated higher agreements with the web server results, than contradictions. The tool is
accessible at http://resource.ibab.ac.in/TIPMaP.
Conclusion: The newly developed online tool forms a reliable means for identification of alternatively spliced
transcript-isoforms that may be differentially expressed in various tissues, cell types or physiological conditions. Thus,
by making better use of existing data, TIPMaP avoids the dependence on precious tissue-samples, in experiments
with a goal to establish expression profiles of alternative splice forms – at least in some cases.
Keywords: Alternative splicing, Alternatively spliced, Microarray, Affymetrix, Azoospermia, Transcript isoforms, mRNA
isoforms, Transcriptome, Gene expressionBackground
Differential gene expression is a pre-requisite for normal
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stated.expression at the mRNA level. DNA microarrays have
been extensively used to list differentially transcribed
genes across tissues or conditions. The generated ex-
pression data is usually deposited in repositories such as
Gene Expression Omnibus (GEO) [1] and ArrayExpress
[2]. Many designs of microarrays have been in use,
among which Affymetrix chips have been popular.
Most of the microarray based gene expression studies
focused on identification of differentially regulated
‘genes’, but not their ‘alternatively spliced transcriptLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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tive splicing [3] and there are evidences for association
of alternatively spliced forms with diseases/disorders
[4-7]. These mRNA-forms can be potential targets for
disease treatments as well [5,8,9]. Hence, it is important
to catalogue expression of specific transcripts for as
many genes as possible.
While exon arrays [10-12] and RNA-sequencing
[13,14] are being used for expression profiling of alter-
natively spliced forms, it is possible to identify the
expression status of some transcripts using gene ex-
pression data, which already exists for a huge variety of
tissues and conditions, across different species. This
can be relatively more effective with standard 3′ Affymetrix
microarrays due to the following reasons: a) the average
number of probes per gene/transcript is higher [15], b) it is
possible to get absolute calls (transcribed/not-detected),
which are compatible with our recent algorithm for deriv-
ing a consensus expression status across multiple hybridiza-
tions/studies [16] and c) these microarrays are particularly
the most commonly used platforms (specific statistics in re-
sults and discussion sections). In fact, scientists have used
such data and identified differentially regulated alternatively
spliced forms. They realigned the probe sequences to tran-
scripts from National Center for Biotechnology Information
(NCBI), Ensembl, UniGene or AceView and analyzed the
data. But such efforts have been limited to a few tissues
or conditions [17-21]. Brainarray database has rea-
ligned probes to different transcripts, and generated
files with probe-clusters that include transcript-
specific probes as well as those common to multiple al-
ternatively spliced forms [22]. Since these two types of
probes cannot be easily identified, expression profiles
obtained using these files might not be very useful for
identifying transcript-specific expression status. A few
algorithms were also developed to tap the transcript
level expression data from gene arrays [12,23,24]. All
these previous efforts show that the already existing
expression data from standard Affymetrix gene arrays
can be used to obtain insights into differential regula-
tion of specific transcript isoforms in different condi-
tions and tissues. However, there is no online tool
available to facilitate such analysis. In addition, it is
becoming evident that not all the previously used
microarray probes are of good quality. Earlier reports
have shown that, many microarray probes do not have
100 percent identity, along their entire length, to any
transcript [25]. There are also evidences of improved
accuracy in microarray results on removal of probes
with improper annotations [26]. We developed TIP-
MaP to fill the current void. Further, we experimentally
validated the results obtained from this tool for a few
transcripts relevant to the non-obstructive azoosper-
mia (NOA) disease.Implementation
Probe and transcript sequences
RefSeq transcript sequences (FASTA format) for human
[27], mouse [28] and rat [29] were downloaded from
NCBI. Probe sequences for 3′ gene expression arrays
(FASTA format) were downloaded from Affymetrix [30].
Gene expression data
Raw gene expression data files (.CEL), produced using
31 standard 3′ human, mouse and rat Affymetrix plat-
forms are being downloaded from GEO [1]. About 4000
experiments have been downloaded on priority. In
addition, a provision has been created for automatic
downloading as per user’s need.
Perform BLAST
Basic Local Alignment Search Tool (BLAST) version
2.2.25 was downloaded from NCBI [31]. Local RefSeq
transcript databases, for human, mouse and rat species,
were set up for BLAST operation, using formatdb
program. The blastall program was used to align each
platform’s probe sequences to local transcript databases.
Generate transcript specific probe-clusters
Alignment results were parsed to identify probes that
map to each transcript. In a significant number of cases
one or more probes showed a reliable match to only one
splice variant; these probes uniquely mapped to specific
transcripts with 100 percent sequence identity, and
along their complete length (25 bases). Using such
probes, ‘transcript-specific probe-clusters’ were derived
and stored as a new chip definition file (CDF), for every
platform considered. Such ‘transcript-specific probe-
clusters’ were derived for single-transcript-genes and
multi-transcript-genes.
Process gene expression data
Bioconductor’s makecdf package [32] was used to make
CDF environments for every new CDF file. These new
CDF environments, Microarray Suite 5.0 (MAS5) and
Robust Multi-Array Average (RMA) algorithms of
Bioconductor’s affy [33] and simpleaffy packages [34]
were used for data normalization. RMA-normalized gene
expression data is used to list differentially regulated
transcripts across the conditions or groups, chosen by
the user. For every transcript in a group, an average sig-
nal intensity is calculated (across hybridizations or
GSMs in a group selected by the user) and a t-test is
performed, using CPAN modules such as Statistics::
TTEST [35] and Statistics::Distributions [36] to identify
transcripts, whose average signal intensities are signifi-
cantly different (p-value < = 0.05) between the groups or
GSM-sets identified by the user. MAS5 processed gene
expression data is used to derive differentially detected
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cluster is labeled as ‘present’ (if the p-value derived is
equal to or less than 0.05), ‘absent’ (p-value is equal to or
greater than 0.065) and ‘marginal’ (p-value is greater
than 0.05 and less than 0.065). For every transcript in a
group, a consensus call is derived across GSMs selected
by the user. A transcript is labeled as ‘transcribed’, if
majority of GSMs or hybridizations have ‘present’ as de-
tection call. For example, a transcript reported to be
transcribed in 4 hybridizations and not-detected in one
hybridization, would be shown as transcribed with a per-
centage detection of 80. Similarly, a transcript is labeled
as ‘not-detected’, if majority of GSMs or hybridizations
have ‘absent’ as detection call and a transcript is labeled
as ‘no-call’, if there are equal present and absent calls.
Scripts and programs
Perl scripts were written to identify and group the
transcript-specific probes, create new CDF files and pre-
dict differentially regulated or detected transcripts. R
scripts were written and R packages were used to
process raw gene expression data. Perl, HTML and CGI
scripts were used in interface development.
Experimental validation by reverse transcription PCR
Transcript selection
Data from a specific study (E-TABM-234, ArrayExpress
[2]) on gene expression profiling, which used Affymetrix
chip (human genome U133 plus 2.0 array), was proc-
essed using TIPMaP (‘process data’ option in the inter-
face). Expression at transcript level was obtained using
the data from this study, across the 31 hybridizations
for non-obstructive azoospermia (Johnsen score counts
ranging from 2 to 8). The resulting transcripts were
grouped into 10 sets based on the reliability of
expression status. The reliability, which reflected the
consistency, was in turn determined by the percentage
of hybridizations with the same expression status. For
example, transcripts in top-set (rank 1) had same ex-
pression pattern across 90 or higher % of hybridiza-
tions. Similarly, the genes designated as transcribed in
non-obstructive azoospermia were also downloaded
from MGEx-Tdb [16] and grouped into 10 different
reliability ranks. The following selection criteria were
then applied:
a) Genes should code for multiple transcripts.
b) Genes should be transcribed as per MGEx-Tdb and
should belong to reliability ranks 1–5.
c) Transcripts encoded by these genes should show a
differential expression status in the non-obstructive
azoospemic condition, as per TIPMaP – i.e., one
transcript should be transcribed and the other ‘not-
detected’. In addition, the transcripts should belongto reliability ranks 1 to 3 for both transcribed and
not-detected status of expression.
d) At least 6 probe-pairs should be used to derive an
expression call for a transcript.
Experiments
Research on humans was carried out in compliance with
the Helsinki declaration and the procedures have been
approved by Institutional Biosafety Committee (IBSC),
Institute of Bioinformatics & Applied Biotechnology
(IBAB) and Ankur hospitals. Testicular biopsy samples
were obtained for four non-obstructive azoospermic
donors of 30 to 38 years age, who provided consent after
being informed about the use of the sample for studies,
and were stored in RNA later solution (Ambion, cat
no: AM7020). RNA was isolated using RiboPure kit
(Ambion, cat no: AM1924). The RNA was confirmed to
be of good quality by electrophoretic and spectrophoto-
metric analysis. About 2.2 μg of RNA was used for
cDNA synthesis (Thermo scientific, verso cDNA synthe-
sis kit cat no: AB-1453/B). PCR was performed using
DyNAzyme II DNA Polymerase (Thermo scientific, cat
no: F-501 L) and transcript-specific primers. RT-PCR
products were checked on 10% polyacrylamide gel and
the gel images were captured using G:BOX Chemi XT 4
instrument (Syngene) [see Additional file 1 for primer
details].
Resource use
Three simple steps have to be followed to identify differ-
entially regulated or detected alternatively spliced forms.
Step 1, Choose datasets
Specific GEO series (GSEs) have to be selected to start
the analysis. The user can, however, begin the query with
one or more GEO series (GSE IDs) or sample identifiers
(GSM IDs). If specific GEO datasets have not been iden-
tified yet, the user can also begin with genes (official
gene symbols) or RefSeq transcript IDs or general key-
words. Search by keywords results in display of corre-
sponding GSE IDs and summary of the experiments.
When queried with gene or transcripts, the tool displays
the GSEs that have been already downloaded, but only
those with information about the expression status of
the queried gene/transcript. This page also includes
expression status (detection status: transcribed, ‘T’; not-
detected, ‘ND’; and marginal, ‘M’ and RMA-processed
signal intensity) of the queried genes and their transcript
IDs. Search by GSM identifier displays GSE ID, GEO
platform identifier (GPL ID), title, source name, charac-
teristics and description.
Clicking the displayed GSE ID or search by GSE iden-
tifier results in a list of corresponding GSMs along with
GPL ID, title, source name, description, characteristics
Chitturi et al. BMC Genomics 2013, 14:922 Page 4 of 10
http://www.biomedcentral.com/1471-2164/14/922and a check box. The user has to then select the specific
GSMs and group them, as shown in step 2 below.
Step 2, Create group (s)
To start an analysis, user has to create one (to know ab-
solute expression status) or two (to find the differential
expression status) group(s). Samples or GSMs with simi-
lar biological conditions can be grouped. A group can be
created by selecting the check boxes provided for each
GSM, and then by clicking on ‘Group all selected GSMs’.
A group can have any number of GSMs and any number
of groups can be made, but the tool performs analysis
across 2 groups at a time. For example, if three groups
are made, the tool compares, and provides results for,
groups 1 vs. 2, groups 1 vs. 3 and groups 2 vs. 3.
Step 3, Choose expression type
The tool can be queried for differential status (up and/or
down regulation) and/or absolute calls (transcribed or
not-detected expression status). Since the number of
probes that uniquely map to each transcript varies (see
Table 1), and since the reliability of the transcription
profiles (output) depends on the number of such good
probes, an option is provided in the query page to set
thresholds for the number of probes.
Output
Transcripts with differential ‘regulation’ are listed along
with their gene names, RefSeq transcript ID, mean signalTable 1 Distribution of transcript-specific probes and transcri
No. of transcript-specific probes N
HG U133 Plus 2 Mouse
STGs* MTGs** STGs
1 129 363 120
2 104 192 108
3 77 106 80
4 95 88 103
5 83 60 78
6 108 68 112
7 147 49 131
8 252 63 189
9 444 87 308
10 910 137 617
11 4850 662 7006
> = 12 4734 383 5007
Total no. of transcripts*** 11933 2258 13859
Total no. of genes 11933 1773 13859
Total no. of transcript specific probes 195511 21305 218403
*STGs: transcripts from single-transcript-genes (transcripts to which the probe-clust
**MTGs: transcripts from multi-transcript-genes (transcripts to which the probe-clus
***Total number of transcript-specific probe-clusters is same as total number of tranintensity for each group, regulation status, fold change
and p-value. Transcripts with differential ‘detection’ (ab-
solute calls) are listed along with their gene names,
RefSeq transcript ID, detection status and percentage de-
tection. The analysis results can be exported in a tab
separated text file. Each RefSeq transcript ID is linked to
basic transcript and the corresponding gene and protein.
All these information have been downloaded from NCBI
and UniProt [37] databases and stored in a MySQL Rela-
tional Database Management System (RDBMS). Gene
information section displays NCBI ID, official symbol,
description, aliases, Entrez-summary, chromosomal loca-
tion, orientation, size, sequence and OMIM IDs. Protein
information provides details for protein isoforms, with
corresponding sequence, function, molecular weight and
amino acid length. Transcript information includes tran-
script ID, graphical display of the transcript-structure
(exons and introns) and sequences of the corresponding
gene, exons and introns. Selected exons, introns or
exon-intron junctional sequences can be scanned for ex-
perimentally proven branch sites and splice factor bind-
ing sites. These experimentally identified sites were
taken from SpliceAid2 [38]. In addition, links to RNAa-
nalyzer [39], RESCUE-ESE [40], ESRsearch [41], ACES-
CAN2 [42] and WebLogo [43] are provided to perform
structural and sequence analysis on selected sequences.
There are also links to other alternative splicing re-
sources, ProSplicer [44], AceView [45], fast DB [46],
ASG [47], SpliceMiner [48] and ASTRA [49]. BLASTpt-specific probe-clusters across platforms
o. of transcript specific probe-clusters
430 2 HG U133 A MG U74 Av2 Rat 230 2
MTGs STGs MTGs STGs MTGs STGs MTGs
143 86 185 67 32 150 83
69 61 107 70 27 128 42
51 40 53 91 22 107 21
48 58 39 49 15 129 15
28 51 26 42 10 139 13
16 82 47 44 9 158 10
23 110 22 56 7 184 6
32 181 33 55 11 267 19
33 365 51 73 7 510 14
48 718 77 54 9 1029 33
398 3475 342 88 12 5973 135
219 1941 130 5587 219 2565 40
1108 7168 1112 6276 380 11339 431
892 7168 953 6276 340 11339 385
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sults. Transcript-specific probe-cluster gives details of
the probes, which are used to create transcript specific
probe-set. In addition, probe’s X and Y co-ordinates,
matched start and end positions on the transcript, per-
centage identity and coverage are also displayed. Expres-
sion profile for all transcripts in a GSE (across GSMs)
can be viewed using the browse option.
An automated downloading and processing option is
enabled for the selected, commonly used, 31 platforms.
If the user selects GSEs that are not already downloaded,
they will be downloaded and processed on priority and
he/she will be intimated by an automated e-mail re-
sponse. The tool’s schema is given in Figure 1.Results and discussion
Data compiled
As of September 2013, data from 41,925 experiments
were deposited in GEO. These include 31,034 gene ex-
pression profiling studies, of which 14,625 studies used
Affymetrix chips. Affymetrix data from human (5954),
mouse (4914) and rat (765) species formed the bulk.
About 80 percentage of these experiments were per-
formed using 31 (13 for human, 9 for mouse and 9 for
rat) 3′ Affymetrix gene expression arrays. The other ex-
periments include those done using 4 other 3′ Affyme-
trix gene expression arrays, which could not be included
as the required CDF files were either modified or un-
available, and exon arrays - for which online tools [50]
already exist. A list of all available platforms is available
in the statistics section of the interface.Figure 1 Schematic representation of TIPMaP. Description: The figure re
as well as the details about the web interface.TIPMaP uses reanalyzed gene expression data, gener-
ated from the selected 31 platforms, to predict differen-
tially regulated or detected transcripts. Currently the
data correspond to 6000 biological conditions across 3
species. The tool provides expression data for 14670,
15621 and 12289 genes, and 17640, 15947 and 12355
RefSeq transcripts for human, mouse and rat species
respectively (across all platforms, individual platforms
details are available in the statistics section of the
interface).
Blast results
Only ‘good probes’, i.e., those with 100% identity and
coverage, were considered. Among such good probes,
which formed 63% of the total probes, 68% matched
uniquely to a specific transcript. Majority of them
mapped to single-transcript-genes from NCBI RefSeq.
For example, in the human genome U133 plus 2 array,
90% of transcript-specific probes corresponded to single-
transcript-genes, while the remaining probes uniquely
mapped to multi-transcript-genes [see Additional file 2,
for distribution of transcript-specific probes across tran-
scripts, genes & platforms]. These transcript specific
probes were used to produce probe clusters specific to
each transcript. Plenty of such probe-clusters indeed
mapped uniquely to specific transcripts and majority of
probe-clusters had three or more probes. For example,
of the 14191 transcript specific probe-clusters from the
human genome U133 plus 2 array, 492 had one probe
each and 296 had 2 probes each, while 13403 had 3 or
more probes in each cluster. These probe-clusters corre-
sponded to 11933 single-transcript-genes and 2258presents the steps involved in data collection, processing and storage
Chitturi et al. BMC Genomics 2013, 14:922 Page 6 of 10
http://www.biomedcentral.com/1471-2164/14/922transcripts from multi-transcript-genes. Table 1 provides
a glimpse of the probe-distribution across probe-clusters
for 5 widely used platforms [see Additional file 3 for
complete details across platforms]. Probe specificities to
transcripts, for each platform, can be viewed in the
statistics section of the interface. BLAST alignment
results and transcript specific probe-clusters can be
downloaded.
Quality checks
Each step of the pipeline (aligning probes to tran-
scripts, parsing blast result, identifying transcript spe-
cific probe-clusters, creating transcript specific CDF
file, processing using R, retrieving and displaying of
differentially regulated or detected alternatively spliced
forms) was checked manually to ensure that the
software works as intended.
Comparison of TIPMaP features with 14 other re-
sources, reported earlier for similar applications, indi-
cated that the newly developed tool is better than other
resources [51].
Experimental validation results
A set of 10 genes and 21 transcripts met the selection
criteria (as described in the methods section). Expression
pattern for these 21 transcripts were verified by RT-PCR
[see Table 2]. Agreement pattern between TIPMaP and
RT-PCR can be categorized in to three sections:
a) Complete agreement (57%): Eight transcripts found
to be transcribed in all 31 hybridizations, with
no ‘not-detected’ or ‘marginal’ calls, (indicated as
31-0-0) as per TIPMaP, were also transcribed in
all 4 NOA samples as per RT-PCR. Similarly, 4
transcripts with a 100% profile of not being detected
(0-31-0) in TIPMaP, were also not-detected in all
samples.
b) Partial agreement/contradiction (29%): There were
six transcripts which did not have a consistent
detection call across 31 hybridizations (e.g.,
transcript NM_001160301.1 of DPYD gene had a
profile of 1-30-0). Four of 6 such cases showed par-
tial agreement. In the other two cases the experi-
mental results contradicted the majority calls in
TIPMaP.
c) Contradiction (14%): There was one transcript that
was transcribed (31-0-0) in all 31 hybridizations as
per TIPMaP, but was not-detected in all 4 NOA
samples as per RT-PCR, which accounted to 4% of
contradiction. There were two transcripts which
were not-detected (0-31-0) in all 31 hybridizations
as per TIPMaP, and were transcribed in all 4 NOA
samples as per RT-PCR, which accounted to 10%
contradiction. This 10% contradiction might beattributed to the higher sensitivity of RT-PCR com-
pared to microarray.
Results from TIPMaP matched with RT-PCR in 70%
of the cases (i.e., 58 out of 84 total experiments, 4 sam-
ples and 21 transcripts). When we considered only those
transcripts with ‘transcribed’ or ‘not-detected’ status in
all 31 hybridizations, the percentage agreement between
the results was 80% [see Additional file 4 for RT-PCR
and TIPMaP results comparative summary].
These results indicate that the new tool can be used to
short-list transcripts, which are differentially regulated
or detected in a tissue or a physiological condition, for
further studies, using already existing microarray data-
sets. Molecular biologists and bioinformaticians might find
various uses for the additional information provided by the
tool. The additional information includes the consistency of
expression type across hybridizations, the number of ‘good
probes’ that uniquely map to the transcripts and position
on the transcripts where these ‘good probes’ map.
Conclusion
TIPMaP can be used to efficiently identify some of the
differentially regulated transcripts from existing data
generated using standard 3′ Affymetrix gene expression
arrays. Even though further experimental validations are
required for confirming the expression status of identi-
fied transcripts, the tool provides an easy way to make
better use of available transcriptomics data across vari-
ous mammalian tissues and conditions. The predictions
by TIPMaP seem to be even more reliable in cases
where the 100% hybridizations agree with the tran-
scribed status, as indicated by 89% agreement during the
current experimental validations. The tool aids in the
differentiation of expression profiles with ‘higher reliabil-
ity’ from those with ‘lower reliability’ based on their
consistency of expression across hybridizations and
number of transcript-specific probes used to predict the
expression. Thus the tool can help to use the existing
gene expression microarray data to short-list some of
the transcripts with specific type of expression, across
tissues and conditions, for further studies. It can also re-
duce the need for novel experiments involving human
and animal samples from various tissues and conditions.
Availability and requirements
Project name: TIPMaP
Project home page: http://resource.ibab.ac.in/TIPMaP
Operating system(s): Platform independent
Programming language: Perl based CGI and HTML
scripts
Other requirements: Java
Tested on: Mozilla and Google chrome browsers
Availability: Free
Table 2 RT-PCR results for 10 genes and 21 transcripts
Gene name RefSeq transcript ID (EPL)* Gel images** RefSeq transcript ID (EPL) Gel images
DPYD NM_000110.3 (161) NM_001160301.1 (157)
HNMT NM_006895.2 (160) NM_001024075.1 (142)
PAFAH1B2 NM_001184748.1 (164) NM_002572.3 (184)
RPS6KA5 NM_182398.1 (84) NM_004755.2 (165)
EGFR NM_005228.3 (179) NM_201282.1 (143)
NM_201284.1 (151)
TCF21 NM_003206.3 (186) NM_198392.2 (212)
KDELR3 NM_006855.2 (190) NM_016657.1 (200)



















Table 2 RT-PCR results for 10 genes and 21 transcripts (Continued)
GAD1 NM_000817.2 (204) NM_013445.3 (149)
GREB1 NM_014668.3 (166) NM_033090.2 (172)
*EPL: Expected product length, in nucleotides, for each transcript is mentioned in brackets.
**Gel images: lane 1: molecular weight marker, lanes 2-5: NOA samples 1-4 and lane 6: no template control.
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Additional file 1: Primers used for reverse transcription and
polymerase chain reaction (RT-PCR), and the expected product
lengths, for various transcripts. The table includes gene name,
transcript ID, forward and reverse primers used in RT-PCR experiments
and expected product length.
Additional file 2: Distribution of transcript-specific probes across
transcripts, genes and platforms. The table describes the counts and
percentages of transcript specific-probes for single-transcript-genes and
multi-transcript-genes, for each platform.
Additional file 3: Distribution of transcript-specific probes and
transcript-specific probe-clusters across platforms. The table
describes the distribution of transcript-specific probes and of transcript-
specific probe-clusters for single-transcript-genes and multi-transcript
genes, across platforms.
Additional file 4: Summary of RT-PCR and TIPMaP comparisons. The
details include gene name, detection status from MGEx-TDB, detection
status and hybridization summary from TIPMaP and agreement between
TIPMaP and RT-PCR results.
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